Dibromodulcitol (NSC-104800)--clinical brochure.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D001966:Bromine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D002241:Carbohydrates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D004285:Dogs; D005260:Female; D000882:Haplorhini; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice
D000970:Antineoplastic Agents; D002241:Carbohydrates; D001966:Bromine